ethyl 1-(ethylsulfonyl)piperidine-4-carboxylate

Catalog No. :
ACTGCY092
CAS No. :
832118-87-3
Molecular Formula :
C10H19NO4S
Molecular Weight :
249.1

IUPAC Name:ethyl 1-(ethylsulfonyl)piperidine-4-carboxylate

ethyl 1-(ethylsulfonyl)piperidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$52.00Login to see priceIn stockInquiry
5g97%$157.00Login to see priceIn stockInquiry
25g97%$753.00Login to see priceInquiryInquiry
100g97%$2381.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameethyl 1-(ethylsulfonyl)piperidine-4-carboxylate
IUPAC Nameethyl 1-(ethylsulfonyl)piperidine-4-carboxylate
MDL No.MFCD04969919
Molecular FormulaC10H19NO4S
Molecular Weight249.1
SMILESO=C(C1CCN(S(=O)(CC)=O)CC1)OCC
InChI KeyFILRAUDHQATKGC-UHFFFAOYSA-N
Synonymethyl 1-(ethylsulfonyl)piperidine-4-carboxylate;4-Piperidinecarboxylic acid, 1-(ethylsulfonyl)-, ethyl ester
CAS No.832118-87-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTGCY092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGCY092 route product structure diagram
    ACTGCY092832118-87-3 In Stock
Inquiry

2. ACTGCY092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGCY092 route product structure diagram
    ACTGCY092832118-87-3 In Stock
Inquiry

Comments (0)